中國電影(600977.SH):總體來看,今年總票房有望超過去年
格隆匯5月27日丨中國電影(600977.SH)在業績説明會上表示,今年春節檔在票房創新高的同時,還伴隨有平均票價的下降、觀影人次的上升;五一檔在出遊熱的背景下,票房和觀影人次均超過了去年同期,均呈現了非常喜人的發展態勢。從待上映的作品來看,暑期檔、國慶檔公司都儲備了不少優秀作品。在進口影片方面,也是呼聲高、觀眾期待的影片都盡力保障供給,支持推廣。所以,總體來看,我們認為今年總票房有望超過去年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.